Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Reaches New 52-Week High – Time to Buy?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) reached a new 52-week high during mid-day trading on Tuesday. The company traded as high as $15.98 and last traded at $15.9760, with a volume of 417,025 shares. The stock had previously closed at $15.91.

Bayer Aktiengesellschaft Stock Down 1.9%

The company’s 50 day moving average price is $13.61 and its 200 day moving average price is $12.65. The company has a quick ratio of 0.67, a current ratio of 1.04 and a debt-to-equity ratio of 1.05. The firm has a market capitalization of $61.47 billion, a price-to-earnings ratio of -37.24, a P/E/G ratio of 2.00 and a beta of 0.57.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last released its earnings results on Tuesday, November 3rd. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.02). The firm had revenue of $11.25 billion during the quarter, compared to analyst estimates of $11.21 billion. Bayer Aktiengesellschaft had a negative net margin of 3.12% and a positive return on equity of 16.10%. As a group, research analysts forecast that Bayer Aktiengesellschaft will post 1.28 earnings per share for the current fiscal year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft is a German life sciences company headquartered in Leverkusen. Founded in 1863, it develops products and services in pharmaceuticals, consumer health and agriculture. Its Pharmaceuticals business offers prescription medicines, including treatments in areas such as cardiovascular disease, oncology, women’s health and eye care. Consumer Health sells nonprescription medicines and self-care products, with brands including Claritin, Aleve and One A Day. Through its Crop Science business, Bayer provides seeds, crop protection products and agricultural solutions for farmers.